Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders.

MLA

Barco, A., et al. “Correlations between Cerebrospinal Fluid Biomarkers, Neurocognitive Tests, and Resting-State Electroencephalography (RsEEG) in Patients with HIV-Associated Neurocognitive Disorders.” Journal of NeuroVirology, vol. 28, no. 2, Apr. 2022, pp. 226–35. EBSCOhost, https://doi.org/10.1007/s13365-021-01047-y.

APA

Barco, A., Orlando, S., Stroffolini, G., Pirriatore, V., Lazzaro, A., Vai, D., Guastamacchia, G., Noce, G., Atzori, C., Trunfio, M., Bonora, S., Di Perri, G., & Calcagno, A. (2022). Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. Journal of NeuroVirology, 28(2), 226–235. https://doi.org/10.1007/s13365-021-01047-y

Chicago

Barco, A., S. Orlando, G. Stroffolini, V. Pirriatore, A. Lazzaro, D. Vai, G. Guastamacchia, et al. 2022. “Correlations between Cerebrospinal Fluid Biomarkers, Neurocognitive Tests, and Resting-State Electroencephalography (RsEEG) in Patients with HIV-Associated Neurocognitive Disorders.” Journal of NeuroVirology 28 (2): 226–35. doi:10.1007/s13365-021-01047-y.